These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 182355)

  • 41. Esophageal complications in the treatment of oat cell carcinoma with combined irradiation and chemotherapy.
    Chabora BM; Hopfan S; Wittes R
    Radiology; 1977 Apr; 123(1):185-7. PubMed ID: 191871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure.
    Johnson RE; Brereton HD; Kent CH
    Lancet; 1976 Aug; 2(7980):289-91. PubMed ID: 59858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of oat cell carcinoma of the lung: complete remissions, acceptable complications, and improved survival.
    Greco FA; Richardson RL; Schulman SF; Stroup S; Oldham RK
    Br Med J; 1978 Jul; 2(6129):10-1. PubMed ID: 209843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combination chemotherapy and radiation therapy for small cell carcinoma of the lung].
    Hara N; Ichinose Y; Motohiro A; Noge S; Miyake J; Ohta M; Hata K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):80-5. PubMed ID: 3002286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Means of improving the chemoradiotherapy of small cell cancer of the lung].
    Monakhov BV; Borisevich NV; Akyshbaev AA
    Vopr Onkol; 1988; 34(6):718-21. PubMed ID: 2839938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial.
    Bunn PA; Lichter AS; Makuch RW; Cohen MH; Veach SR; Matthews MJ; Anderson AJ; Edison M; Glatstein E; Minna JD
    Ann Intern Med; 1987 May; 106(5):655-62. PubMed ID: 3032033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination chemotherapy with cyclophosphamide, vincristine, cisplatin and etoposide (COPE) combined with radiotherapy for small cell lung cancer.
    Nam YJ; Choi CW; Shin SW; In KH; Kang KH; Kim JS; Choi YH; Kim CY; Choi MS
    Korean J Intern Med; 1995 Jan; 10(1):32-7. PubMed ID: 7626554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer.
    Einhorn L; Krause M; Hornback N; Furnas B
    Cancer; 1976 May; 37(5):2414-6. PubMed ID: 56987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
    Brooks BJ; Seifter EJ; Walsh TE; Lichter AS; Bunn PA; Zabell A; Johnston-Early A; Edison M; Makuch RW; Cohen MH
    J Clin Oncol; 1986 Feb; 4(2):200-9. PubMed ID: 3003259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of radiation therapy in combination with chemotherapy in extensive oat cell cancer of the lung: a randomized study.
    Williams C; Alexander M; Glatstein EJ; Daniels JR
    Cancer Treat Rep; 1977 Nov; 61(8):1427-31. PubMed ID: 200357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytologic characteristics of oat-cell carcinoma of the lung in relation to the effect of chemotherapy.
    Horai T; Sone H; Takenaga A; Ikegami H; Matsuda M; Hattori S
    Cancer; 1981 Jan; 47(1):22-6. PubMed ID: 6257371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapy.
    Hornback NB; Einhorn L; Shidnia H; Joe BT; Krause M; Furnas B
    Cancer; 1976 Jun; 37(6):2658-64. PubMed ID: 181121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized trial comparing chemotherapy alone and chemotherapy plus chest irradiation in limited stage small cell lung cancer: a preliminary report.
    Ohnoshi T; Hiraki S; Kawahara S; Yamashita H; Yonei T; Ishii J; Egawa T; Kozuka A; Hiraki Y; Kimura I
    Jpn J Clin Oncol; 1986 Sep; 16(3):271-7. PubMed ID: 3022036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
    Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
    Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-drug chemotherapy combined with radiation therapy in small cell carcinoma of the lung.
    Sibille Y; Steyaert J; Francis C; Bosly A; Prignot J
    Eur J Respir Dis; 1983 Feb; 64(2):113-20. PubMed ID: 6299770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 59. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
    Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
    Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.